Nivo Dose Frequency Optimization Lung Trial
ClinicalTrials.gov NCT02713867
Research payments
$379,317
Through program year 2022, $379,317 in research payments was reported against Nivo Dose Frequency Optimization Lung Trial, across 52 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- NCT02713867
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $75 | 1 |
| 2021 | Research | $34,149 | 12 |
| 2020 | Research | $80,564 | 15 |
| 2019 | Research | $264,529 | 24 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kristi McIntyre Dallas, TX Named on 4 payments
- Patrick Ward Cincinnati, OH Named on 3 payments
- Jay Courtright Dallas, TX Named on 3 payments
- Robert Jotte Lone Tree, CO Named on 3 payments
- Tania Cortas Phoenix, AZ Named on 2 payments
- Enrique Perez Carrollton, TX Named on 2 payments
- Juliet Penn Solvang, CA Named on 2 payments
- David Hakimian Niles, IL Named on 2 payments
- Ralph Hauke Omaha, NE Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.